Porous COS@SiO2 Nanocomposites Ameliorate Severe Acute Pancreatitis and Associated Lung Injury by Regulating the Nrf2 Signaling Pathway in Mice

Qixiang Mei,Guoying Deng,Zehua Huang,Yue Yin,Chunlin Li,Junhui Hu,Yang Fu,Xingpeng Wang,Yue Zeng
DOI: https://doi.org/10.3389/fchem.2020.00720
IF: 5.5
2020-10-07
Frontiers in Chemistry
Abstract:Severe acute pancreatitis (SAP) is associated with high rates of mortality and morbidity. Chitosan oligosaccharides (COSs) are agents with antioxidant properties. We developed porous COS@SiO<sub>2</sub> nanocomposites to study the protective effects and mechanisms of COS nanomedicine for the treatment of acute pancreatitis. Porous COS@SiO<sub>2</sub> nanocomposites released COSs slowly under pH control, enabling sustained release and maintaining the drug at a higher concentration. This study aimed to determine whether porous COS@SiO<sub>2</sub> nanocomposites ameliorate SAP and associated lung injury. The SAP model was established in male C57BL/6 mice by intraperitoneal injection of caerulein. The expression levels of myeloperoxidase, malondialdehyde, superoxide dismutase, nuclear factor-kappa B (NF-κB), the NOD-like receptor protein 3 (NLRP3) inflammasome, nuclear factor E2-related factor 2 (Nrf2), and inflammatory cytokines were detected, and a histological analysis of mouse pancreatic and lung tissues was performed. In the SAP groups, systemic inflammation and oxidative stress occurred, and pathological damage to the pancreas and lung was obvious. Combined with porous COS@SiO<sub>2</sub> nanocomposites before treatment, the systemic inflammatory response was obviously reduced, as were oxidative stress indicators in targeted tissues. It was found that Nrf2 was significantly activated in the COS@SiO<sub>2</sub> treatment group, and the expressions of NF-κB and the NLRP3 inflammasome were notably decreased. In addition, this protective effect was significantly weakened when Nrf2 signaling was inhibited by ML385. This demonstrated that porous COS@SiO<sub>2</sub> nanocomposites activate the Nrf2 signaling pathway to inhibit oxidative stress and reduce the expression of NF-κB and the NLRP3 inflammasome and the release of inflammatory factors, thus blocking the systemic inflammatory response and ultimately ameliorating SAP and associated lung injury.
chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is severe acute pancreatitis (SAP) and its related lung injury. SAP is a serious disease associated with high mortality and morbidity, characterized by systemic inflammatory response syndrome, multiple organ dysfunction syndrome, sepsis and other complications. Acute lung injury (ALI) is one of the most severe and earliest - occurring complications in SAP and has an important impact on the risk of death in early - stage SAP patients. By studying the protective effect and mechanism of porous COS@SiO_2 nanocomposites on SAP and related lung injuries, the paper aims to explore an effective treatment method to improve SAP and the lung injuries caused by it. Specifically, the paper studied whether porous COS@SiO_2 nanocomposites can reduce SAP and related lung injuries by regulating the Nrf2 signaling pathway. The Nrf2 signaling pathway plays a key role in antioxidant stress, and oxidative stress is considered to be one of the important pathophysiological mechanisms of AP. Through experiments, researchers hope to verify whether COS@SiO_2 nanocomposites can activate the Nrf2 signaling pathway, inhibit oxidative stress, reduce the expression of NF - κB and NLRP3 inflammasomes and the release of inflammatory factors, thereby preventing the systemic inflammatory response and ultimately improving SAP and related lung injuries.